| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 428 |
| 1 | METHYLPREDNISOLONE | 391 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 370 |
| 3 | TACROLIMUS OINTMENT 0.1% | 370 |
| 4 | PREDNISONE | 330 |
| 5 | MYCOPHENOLATE MOFETIL | 298 |
| 6 | PREDNISOLONE | 296 |
| 7 | PREDNISOLONE ORAL | 296 |
| 8 | PREDNISOLONE ORAL SOLUTION | 296 |
| 9 | METHOTREXATE SODIUM | 287 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN BOTULINUM NEUROTOXIN A/B IMMUNE GLOBULIN | 6 | 0.1463 |
| 1 | SALINE LAXATIVE | 1 | 0.1250 |
| 2 | GLYCERIN 20% | 1 | 0.0588 |
| 3 | SENNA LIQUID | 1 | 0.0323 |
| 4 | BISACODYL SUPPOSITORY | 1 | 0.0303 |
| 5 | DAUNORUBICIN HYDROCHLORIDE | 45 | 0.0273 |
| 6 | PEMIVIBART | 1 | 0.0233 |
| 7 | MIGLITOL | 18 | 0.0187 |
| 8 | DEXTROSE AND SODIUM CHLORIDE | 3 | 0.0180 |
| 9 | THROMBIN TOPICAL RECOMBINANT | 1 | 0.0147 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 912 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 450 |
| 2 | Platinum-based Drug [EPC] | 350 |
| 3 | Alkylating Drug [EPC] | 299 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 266 |
| 5 | Topoisomerase Inhibitor [EPC] | 191 |
| 6 | Kinase Inhibitor [EPC] | 178 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 153 |
| 8 | Microtubule Inhibitor [EPC] | 152 |
| 9 | Asparagine-specific Enzyme [EPC] | 142 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 142 | 0.0105 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 49 | 0.0100 |
| 2 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 3 | 0.0077 |
| 3 | Vasoconstrictor [EPC] | 2 | 0.0067 |
| 4 | Anti-coagulant [EPC] | 10 | 0.0027 |
| 5 | Rifamycin Antibacterial [EPC] | 90 | 0.0025 |
| 6 | Topoisomerase Inhibitor [EPC] | 191 | 0.0025 |
| 7 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 98 | 0.0021 |
| 9 | Somatostatin Analog [EPC] | 13 | 0.0019 |